Skip Navigation

Behavioral Activation and Fluoxetine for Adolescents with Depression

Principal Investigator: Lorie A. Ritschel, PhD

Population: Adolescents 14-17 with depression
 
Summary: This study compares a new form of therapy for depression called Behavioral Activation (BA) to the antidepressant medication fluoxetine. Participants in
the study are randomized to receive treatment with either BA or fluoxetine for 18 weeks. Another aim of the study is to examine the brain functions of
adolescents in both treatment groups. Participants undergo functional Magnetic Resonance Imaging (fMRI) scans before and after treatment.


Procedures: fMRI scans, urine drug screen, questionnaires, interviews

Contact:
Ben Johnson, Sean Carey
Study Coordinators
Phone: 404-727-4799
Email: bnjoh4@emory.edu